The Cancer Service Line (CSL) and the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center (ACC) are delighted to announce the selection of the 2022 Access Accelerator project.
Over the next six months, this team will work closely with innovation and operational support from CSL and PC3I to design and test an intervention to improve patient access to hematologic oncology care. They will also receive mentorship and advising from a broad group of stakeholders representing both inpatient and outpatient hematologic care as well as health system operations and leadership. At the conclusion of the pilot, the project team will present its progress and findings and identify opportunities for scale.
Through the Innovation Accelerator, the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center (ACC) invite applications for initiatives that aim to create and test innovative solutions to address challenges in productivity, efficiency, clinician wellbeing, or access in cancer care at Penn Medicine
Research led by PC3I Faculty Emily Ko showed that implementing telehealth into clinical trials is both safe and feasible.
PC3I Faculty, Fellows, and Staff present 17 abstracts at the 2023 ASCO Quality Care Symposium in Boston, MA.